Cannabis-derived products antagonize platinum drugs by altered cellular transport

This publication has 41 references indexed in Scilit:

• Cisplatin in cancer therapy: Molecular mechanisms of action
  European Journal of Pharmacology, 2014
• An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
  Journal of Pain and Symptom Management, 2013
• Cannabidiol as potential anticancer drug
  British Journal of Clinical Pharmacology, 2013
• Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
  Neurochemistry International, 2012
• The taste of heavy metals: Gene regulation by MTF-1
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
• Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
  The Journal of Pain, 2012
• Drug transporters of platinum-based anticancer agents and their clinical significance
  Drug Resistance Updates, 2011
• Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
  Journal of Pain and Symptom Management, 2010
• Kinetics of H2AX phosphorylation after exposure to cisplatin
  Cytometry Part B: Clinical Cytometry, 2008
• Activity of Metal-Responsive Transcription Factor 1 by Toxic Heavy Metals and H₂O₂ In Vitro Is Modulated by Metallothionein
  Molecular and Cellular Biology, 2003